EMD-67568

Single-particle
3.4 Å
EMD-67568
3D View Gallery
Deposition: 07/12/2025
Map released: 11/03/2026
Last modified: 11/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-67568

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Cryo-EM map of SARS-CoV-2 BA.2.75 Spike Protein (Three RBDs down)

EMD-67568

Single-particle
3.4 Å
EMD-67568
3D View Gallery
Deposition: 07/12/2025
Map released: 11/03/2026
Last modified: 11/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus
Sample: BA.2.75 S

Deposition Authors: Wang M, Peng Q, Yang JY, Luo H, Shi Y
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.
Wang M, Yang J, Tan Y, Yuan S , Shi G, Peng Q, Li Y, Poon VK , Chan CC , Xiao N, Zhang AJ , Xie Y, Li J , Luo H, Fu Y, Chen Y, Compton AA , Zhang Y , Yang Y , Gao GF , Hou H , Chan JF , Yin Y , Shi Y
(2026) Nat Commun , 17 , 1753 - 1753
PUBMED: 41587975
DOI: doi:10.1038/s41467-026-68462-9
ISSN: 2041-1723